Human TACI Protein, ECD (Extracellular Domain), Fc-fusion, Biotinylated, Recombinant
TACI (transmembrane activator and CAMLinteractor), also known as CD267, is a single-pass, type III transmembrane glycoprotein in the TNF receptor superfamily (TNFRSF13B). The TNFRSF members have crucial roles in both innate and adaptive immunity as well as in apoptosis. The extracellular region of TACI contains two TNFR-cysteine rich repeats that mediate interactions with its TNF family ligands, including APRIL/TNFSF13 and BAFF/TNFSF13B. TACI binds both ligands with similar high affinity. Within the TNFRSF, it shares the highest homology with BCMA/TNFRSF17. TACI and BCMA can bind both APRIL and BAFF. TACI is expressed on the cell surface of B cells and activated T cells, but not on resting T cells. TACI may play an important role in B cell development, function and regulation. TACI interacts with calcium-modulator and cyclophilin ligand (CAML). TACI mediates calcineurin-dependent activation of NF-AT, NF-κB and AP-1. TACI is also involved in the stimulation of B- and T-cell function and the regulation of humoral immunity. Mutations in the TACI gene are associated with common variable immunodeficiency 2 (CVID2) and immunoglobulin A deficiency 2 (IGAD2) in humans.
Gene Symbol: TACI; CD267; CVID; RYZN; CVID2; TNFRSF13B
NCBI Gene ID: 23495
Uniprot Entry: O14836
Construct Details: The recombinant human TACI-Fc fusion is expressed as a 391 amino acid protein consisting of Ser2 - Ser165 region of TACI (UniProt accession #O14836) and a C-terminal Fc from human IgG1, which exists as a dimer under non-reducing conditions (see the gel image inserted above).
Source: Human cells stably expressing human TACI-Fc and growing in chemical-defined media with no animal components or antibiotics
Deduced Amino Acid Sequence:
10 20 30 40 50 60
SGLGRSRRGG RSRVDQEERF PQGLWTGVAM RSCPEEQYWD PLLGTCMSCK TICNHQSQRT
70 80 90 100 110 120
CAAFCRSLSC RKEQGKFYDH LLRDCISCAS ICGQHPKQCA YFCENKLRSP VNLPPELRRQ
130 140 150 160 170 180
RSGEVENNSD NSGRYQGLEH RGSEASPALP GLKLSADQVA LVYSTGTHTC PPCPAPELLG
190 200 210 220 230 240
GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
250 260 270 280 290 300
NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE
310 320 330 340 350 360
EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
370 380 390
WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K
M.W.: Calculated molecular mass (kDa): 43.9; Estimated by SDS-PAGE under reducing condition (kDa): 45-50
Calculated PI: 8.45
Calculated extinction coefficients (M-1 cm-1, at 280nm): 54985
Purity: >95% judged by SDS-PAGE under reducing condition (see the gel image above, labeled as "DTT: +")
Formulation: Supplied at 0.5 mg/ml in sterile PBSpH7.4 (carrier & preservative free). The purified recombinant protein was labeled with Biotin (3-5 Biotin per molecule) using the standard procedure.
Endotoxin Level: <0.1 EU per 1 μg of purified recombinant protein determined by the LAL method
Biological Activity: Binds to its ligand BAFF. Inhibits BAFF-mediated signaling activities including NF-κB activation and proliferation of anti-IgM co-stimulated B cells.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
Restriction: This product is not transferable or re-sellable. Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose. Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules. Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction. Your use of this product constitutes acceptance of the terms of this limited use agreement. Please refer to our “terms & conditions” for details. If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.
The product is shipped at 4°C. Upon receipt, centrifuge the product briefly before opening the vial. It is recommended to store small aliquots at the temperature below –20°C for long-term storage and the product is stable for 3 months. The undiluted protein can be stored at 4°C for no more than 2 weeks.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
1. Science, 278:138 (1997).
2. J. Exp. Med. 192:137 (2000).
3. Nature 404:995 (2000).
4. Nature Immunol.1:37 (2000).
5. Nat Genet. 37: 820 (2005)
Product datasheet (pdf) can be downloaded here: FCL0225B-PDS.pdf
Additional supporting documents, including COA and MSDS are available upon request.
FOR RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE IN HUMAN.
Restriction: This product is not transferable or re-sellable. Customer obtain no right to transfer, assign, or sublicense its use rights, or to transfer, resell, package, or otherwise distribute the product, or to use the product for the benefit of any third party or for any commercial purpose. Customer may only use the product in compliance with applicable local, state and federal laws, regulations and rules. Customer may not directly or indirectly use the product or allow the transfer, transmission, export or re-export of all or any part of the product in violation of any export control law or regulation of the united states or any other relevant jurisdiction. Your use of this product constitutes acceptance of the terms of this limited use agreement. Please refer to our “terms & conditions” for details. If you are not willing to accept the limitation of this agreement, G&P Biosciences will accept return of the product for a full/partial refund.